Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tinelli

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Genes and Immunity|September 4, 2015
Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibilityG Bossi, S Mannarino, M C Pietrogrande, et al.
British Journal of Cancer|July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)A Riccardi, P Pugliese, M Danova, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 2, 2000
Etiology and age incidence of precocious puberty in girls: a multicentric studyM Cisternino, T Arrigo, A M Pasquino, et al.
Le Infezioni in Medicina|June 28, 2002
[Evaluation of the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus]A Pan, P Catenazzi, L Ferrari, et al.
Tumori|December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast CancerA Riccardi, S Brugnatelli, M Giordano, et al.
The European Respiratory Journal|July 8, 2000
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patientsS Viglio, P Iadarola, A Lupi, et al.
British Journal of Cancer|February 7, 2001
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple MyelomaA Riccardi, O Mora, C Tinelli, et al.
British Journal of Cancer|February 24, 1998
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple MyelomaA Riccardi, O Mora, S Brugnatelli, et al.
Infection|May 6, 2008
Evolution of antiretroviral prescription and response over a period of 8 years: an Italian multicentre observational prospective cohort studyL Sighinolfi, C Torti, C Zeni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocolA Riccardi, O Mora, C Tinelli, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Genes and Immunity|September 4, 2015
Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibilityG Bossi, S Mannarino, M C Pietrogrande, et al.
British Journal of Cancer|July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)A Riccardi, P Pugliese, M Danova, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 2, 2000
Etiology and age incidence of precocious puberty in girls: a multicentric studyM Cisternino, T Arrigo, A M Pasquino, et al.
Le Infezioni in Medicina|June 28, 2002
[Evaluation of the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus]A Pan, P Catenazzi, L Ferrari, et al.
Tumori|December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast CancerA Riccardi, S Brugnatelli, M Giordano, et al.
The European Respiratory Journal|July 8, 2000
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patientsS Viglio, P Iadarola, A Lupi, et al.
British Journal of Cancer|February 7, 2001
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple MyelomaA Riccardi, O Mora, C Tinelli, et al.
British Journal of Cancer|February 24, 1998
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple MyelomaA Riccardi, O Mora, S Brugnatelli, et al.
Infection|May 6, 2008
Evolution of antiretroviral prescription and response over a period of 8 years: an Italian multicentre observational prospective cohort studyL Sighinolfi, C Torti, C Zeni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocolA Riccardi, O Mora, C Tinelli, et al.
Pageof 14